Research never stops


Feb 13, 2015

Evotec to attend the Discovery Summit 2015

Click on this link to read the whole interview with Evotec's Dr Dirk Ullmann, EVP Lead Discovery, on broad technology platforms in drug discovery.

- read more
Jan 19, 2015

Evotec and C4XD enter collaboration to identify pre-clinical development candidates for stress-related addictive disorder programme

Hamburg, Germany - 19 January 2015: Evotec AG today announced a research collaboration with C4X Discovery Holdings plc to optimise Orexin-1 selective inhibitors discovered through C4XD's unique NMR technology.

- read more
Jan 15, 2015

Evotec achieves further milestones in TargetAD collaboration with Janssen

Hamburg, Germany - 15 January 2015: Evotec AG today announced the achievement of several small, but very important milestones in its TargetAD collaboration with Janssen Pharmaceuticals, Inc. for the identification and selection of novel targets from Evotec's TargetAD database and for the transition of targets into the drug discovery process.

- read more
Jan 07, 2015

Evotec and Padlock Therapeutics announce initial success and extension of long-term collaboration

Hamburg, Germany - 07 January 2015: Evotec AG and Padlock Therapeutics, Inc. announced today that they have successfully completed an initial goal in a programme focused on developing inhibitors of protein-arginine deiminases and have further extended the collaboration that was first signed in January 2014.

- read more